Jay Backstrom
Chief Executive Officer bei SCHOLAR ROCK HOLDING CORPORATION
Vermögen: 6 Mio $ am 31.03.2024
Profil
Zurzeit bekleidet Jay T. Backstrom die Position des Executive VP & Head-Research & Development bei Acceleron Pharma, Inc. Er ist außerdem Mitglied des Vorstands von Autolus Therapeutics Plc. In seiner bisherigen Laufbahn hatte er die Position des medizinischen Direktors des Samuel U. Rodgers Community Health Center, Inc. inne, war Chief Medical Officer bei Celgene Corp., Executive Director-Medical & Scientific Services bei Quintiles, Inc. (Kalifornien) und Vice President-Global Medical & Safety bei Pharmion Corp. Er promovierte an der Temple University School of Medicine und erwarb einen Abschluss an der St Louis University School of Public Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.02.2024 | 352 671 ( 0,45% ) | 6 Mio $ | 31.03.2024 | |
DISC MEDICINE, INC.
-.--% | 14.04.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Jay Backstrom
| Unternehmen | Position | Beginn |
|---|---|---|
| LAVA THERAPEUTICS N.V. | Director/Board Member | 15.06.2022 |
| SCHOLAR ROCK HOLDING CORPORATION | Chief Executive Officer | 20.09.2022 |
Be Biopharma, Inc.
 Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Director/Board Member | 16.12.2021 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Director/Board Member | 01.12.2021 |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Pancreatic Cancer Action Network, Inc. engages in the research, clinical initiatives, patient services, and advocacy for pancreatic cancer. The company was founded in 1999 and is headquartered in Manhattan Beach, CA. | Director/Board Member | 01.07.2023 |
Ehemalige bekannte Positionen von Jay Backstrom
| Unternehmen | Position | Ende |
|---|---|---|
| DISC MEDICINE, INC. | Director/Board Member | 09.06.2023 |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 28.02.2023 |
| ACCELERON PHARMA INC. | Chief Tech/Sci/R&D Officer | 01.12.2021 |
| CELGENE | Chief Tech/Sci/R&D Officer | 01.11.2019 |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Jay Backstrom
| St Louis University School of Public Health | Graduate Degree |
| Lewis Katz School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| LAVA THERAPEUTICS N.V. | Health Technology |
| DISC MEDICINE, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
| Samuel U. Rodgers Community Health Center, Inc. | |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Pancreatic Cancer Action Network, Inc. engages in the research, clinical initiatives, patient services, and advocacy for pancreatic cancer. The company was founded in 1999 and is headquartered in Manhattan Beach, CA. | Health Services |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Health Technology |
Be Biopharma, Inc.
Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Commercial Services |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
